Foley Hoag LLP to present at CBI’s Forum on Effective Patent, IP and Trademark Strategies for the Bio/Pharmaceutical and Medical Device Industries

Boston, MA - October 17, 2007

The Center for Business Intelligence is pleased to announce that Foley Hoag LLP will be presenting a session at the Forum on Effective Patent, IP and Trademark Strategies for the Bio/Pharmaceutical and Medical Device Industries.

Donald R. Ware, Partner and Chair of Intellectual Property Group of Foley Hoag LLP will be presenting a session titled The Proposed New Patent Regime for Follow-on Biologics along with Maggie Shafmaster, Ph.D., Vice President, Intellectual Property Counsel of Genzyme Corporation. Discussion in this session includes:

  • Extent of access to follow-on applications provided to BLA holders and patent owners
  • Mandatory information exchange between follow-on applicant and BLA holder to identify relevant patents, replacing Orange Book
  • Patent challenges by follow-on applicants
  • Selection of patents for early resolution
  • Time periods for infringement suits
  • Notification to BLA holder of follow-on product launch
  • Enforcement mechanisms for BLA holders and patent owners, including preliminary and permanent injunctive relief
  • Patent sanctions for failure to meet deadlines

Join us for this two day event featuring an update on key legislative reforms and USPTO changes. The Congressional Keynote will be presented by Matthew Sandgren, Counsel to Senator Orrin G. Hatch of the U.S. Senate Committee on the Judiciary. The USPTO Keynote will be presented by James A. Toupin, General Counsel of the U.S. Patent and Trademark Office.

For more information about CBI’s Forum on Effective Patient, IP and Trademark Strategies for the Bio/Pharmaceutical and Medical Device Industries or to register, call (800) 817-8601, visit http://www.cbinet.com/patents or e-mail cbireg@cbinet.com.

About CBI Research, Inc.

CBI is a privately held, world-class conference company that focuses on producing high-level programs for executive decision-makers who face strategic issues in domestic and international markets. CBI has provided information and networking opportunities for thousands of senior- level executives in various industries for over 10 years. CBI produces over 100 conferences and webinars yearly. More information is available at www.cbinet.com.

About Foley Hoag LLP

Foley Hoag LLP is a leading national law firm in the areas of dispute resolution, intellectual property, and corporate transactions for emerging, middle-market, and large-cap companies. With a deep understanding of clients’ strategic priorities, operational imperatives, and marketplace realities, the firm helps companies in the biopharma, high technology, energy technology, financial services and manufacturing sectors gain competitive advantage. 250 lawyers located in Boston, Washington, and the Emerging Enterprise Center in Waltham, Massachusetts join with a network of Lex Mundi law firms to provide global support for clients’ largest challenges and opportunities. For more information visit www.foleyhoag.com.

CATEGORIES

Healthcare, Life Sciences, Energy Technology and Renewables, Technology Transfer & Licensing, Venture Capital & Emerging Companies, Business, Intellectual Property Litigation, Intellectual Property, Patent, Trademark